Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Medicare Conference In Brief

This article was originally published in The Gray Sheet

Executive Summary

CED lives: "I would like to stop the rumor that CED is dead," said Steve Phurrough, MD, director of CMS' Coverage & Analysis Group May 3 at AdvaMed's Medicare policy meeting in Baltimore. "We've had some issues develop" with the draft policy for coverage-with-evidence-development, in particular with the Office for Human Research Protections and patient privacy regulations, he said. Such issues led to "false starts" in the National Oncologic PET registry, which under a January 2005 national coverage decision requires patients to enroll in a registry so they can get certain cancer-monitoring scans (1"The Gray Sheet" March 20, 2006, p. 9). But most issues have been resolved over the last several months, said Phurrough, and the PET registry is scheduled to open May 8. CMS plans to release a second draft guidance document to address and ask for comments on those concerns in the near future...
Advertisement

Related Content

Frustrated Manufacturers Will Go To HCPCS Meetings With Few Expectations
Frustrated Manufacturers Will Go To HCPCS Meetings With Few Expectations
MDMA Annual Meeting In Brief
MDMA Annual Meeting In Brief
DME Suppliers: Competitive Bidding Rebate Program Could Taint Industry
Imaging Registry Begins: Coverage-With-Evidence Policy Gets A Second Wind
DME Stakeholders Take CMS To Task For HCPCS Coding Decisions
Informed Consent Issues Proving Tricky In CMS Evidence-Development Policy
Informed Consent Issues Proving Tricky In CMS Evidence-Development Policy
Adverse Event Reporting To Be Scrutinized By HHS Inspector General In FY ’06
Advertisement
UsernamePublicRestriction

Register

MT023507

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel